Quote: “Every problem has a solution in the end – Tiffany Loh”
Tiffany Loh, Founder & CEO of Revery International Group Bhd maybe petite but her towering ambition has already earned her the “Emerging Brand Legend” award by Branding Association of Malaysia (BAM). Elated at this recognition, she said she was touched in receiving this prestigious award for “her baby” RèLabo representing Malaysia’s first non-injectable anti-aging biotechnology Exosome-based home treatment.
Backed by the company’s own stem cell laboratory utilising stem cell technology to produce its own RèLabo skincare, this represents a significant leap in biotechnology and skincare innovation. Her next game plan is also to position the groundbreaking anti-aging solution harnessing stem cell-derived exosomes combined with potent skincare components that are non-invasive, scienced-back skincare without the need for surgery or downtime globally. Perfect for today’s consumers demanding personalised skincare solutions to combat the effects of “aging from photoaging, lifestyle and the environment.”
Soft-spoken and armed with good looks akin to the girl-next-door albeit of a savvy kind, her love for beauty and wellness combined with technology will revolutionise RèLabo to the next level while establishing it as a global biomedical leader.
Her company, backed by her dream team of 26 women whom she calls her “partners” — encapsulates the end goal of making them all financially independent.
“Do it yourself first and then prove it to your team,” she quipped, taking the lead by example. Acknowledging there there will always be challenges, her belief system affirms that there will always be an end solution.
“I’m already immune to challenges. So, just be patient and calm down to think of how to settle the issue at hand. Sometimes, I’m stressed out, but I am immune already. So, just plan and think clearly,” she advised budding and seasoned entrepreneurs.
In integrating beauty and healthcare, her aim is to create “something so special — apart from current market offerings”. While other companies “do injectables”, she wanted “to do something for consumers (with them) feeling and being happier” by creating the same results for her beauty clients albeit in a “safe way” — meaning “without the need to inject” so they can attest that “there’s a product they can use which is non-injectable”.
Ultimately, her goal is set on the international arena.
“RèLabo embodies our commitment to providing professional and effective anti-aging solutions that empower women to regain their confidence.
“Our breakthrough ingredient in all RèLabo products, Exo-BioComplex, activates skin vitality and effectively combats signs of aging. More than RM10 million was invested in this new e
venture in order for us to harness the full potential of this ingredient to offer a bespoke solution to aging – transcending the barriers posed by intrinsic and extrinsic factors in order to create the safest and most effective solutions for anti-aging.
The anti-aging market is rapidly growing internationally, with growing demand and the need for non-invasive treatments with professional results at home while the consumer demographic seeking anti-aging solutions is becoming younger — particularly among those aged between 26 and 35.
As the first Exosome-based home treatment, RèLabo’s focuses on the concept of “anti-premature aging” by utilising advanced biotechnology to effectively address skin aging issues cause by harsh lifestyle, stress, environmental factors and even UV exposure.
This offers a new direction in skin rejuvenation, elevating the group’s position in the medical-aesthetic industry while opening new opportunities.
As an elite “anti-premature aging” brand tailored for discerning urbanites, RèLabo utilises cutting-edge Exosome technology from stem cells to tackle the initial signs of aging.
As the first Exosome-based home treatment, RèLabo focuses on the concept of “anti-premature aging” by utilising advanced biotechnology to effectively address skin aging issues cause by harsh lifestyle, stress, environmental factors and UV exposure.
